Age (years)
|
63 (49–72)
|
63 (50–74)
|
0.1443
|
Sex (male)
|
200 (64.7)
|
1272 (61.5)
|
0.2775
|
BMI (kg/m2)
|
27.1 (23.1–30.8)
|
26.0 (22.9–30.4)
|
0.1410
|
Geo-economic area
| | |
0.0002
|
European countries with high income
|
198/1263 (15.7)
|
1065/1263 (84.3)
| |
Non-European countries (rest of world) with high income
|
63/649 (9.7)
|
586/649 (90.3)
|
Countries with middle income
|
48/465 (10.3)
|
417/465 (89.7)
|
Severity of ARDS at day 1
| | |
0.9271
|
Mild
|
95 (30.7)
|
619 (29.9)
| |
Moderate
|
144 (46.6)
|
962 (46.5)
|
Severe
|
70 (22.7)
|
487 (23.6)
|
Type of admission
| | |
0.0194
|
Medical
|
211 (68.3)
|
1554 (75.2)
| |
Surgical
|
20 (6.5)
|
123 (6.0)
|
Postoperative (elective)
|
56 (18.1)
|
310 (15.0)
|
Trauma
|
22 (7.1)
|
81 (4.0)
|
Cause of AHRF
|
Pneumonia
|
213 (68.9)
|
1295 (62.6)
|
0.0317
|
Cardiac failure
|
43 (12.9)
|
311 (15.0)
|
0.6051
|
Asthma
|
4 (1.3)
|
29 (1.4)
|
1.0000
|
ARDS (i.e. clinician recognized)
|
103 (33.3)
|
684 (33.1)
|
0.9284
|
COPD
|
29 (9.4)
|
205 (9.9)
|
0.7714
|
Unknown
|
15 (4.9)
|
117 (5.7)
|
0.5652
|
Others
|
54 (17.5)
|
418 (20.2)
|
0.2606
|
ARDS risk factor
| | |
0.1675
|
No risk factor
|
19 (6.1)
|
157 (7.6)
| |
Only indirect risk factors
|
53 (17.1)
|
429 (20.7)
|
Only direct risk factors
|
194 (62.8)
|
1160 (56.1)
|
Both risk factor types
|
43 (13.9)
|
322 (15.6)
|
Illness severity at ARDS onset
|
pH
|
7.37 (7.29–7.43)
|
7.34 (7.26–7.41)
|
<.0001
|
P/F ratio (mmHg)
|
156 (110–213)
|
154 (103–215)
|
0.6845
|
PaCO2 (mmHg)
|
42 (36–50)
|
43 (37–51)
|
0.2751
|
Non-respiratory SOFA score (adjusted for missing values) (ARDS onset)
|
6 (4–9)
|
7 (4–10)
|
0.0010
|
Non-respiratory SOFA score (adjusted for missing values) at day 2
|
6 (4–9)
|
6 (4–10)
|
0.1333
|
Difference in non-respiratory SOFA score (day2-day1) (adjusted for missing values)
|
0 (−2–2)
|
0 (−2–2)
|
0.9598
|
Mechanical ventilation settings at ARDS onset
|
Respiratory rate (set) (breaths/min)
|
18 (15–22)
|
16 (14–20)
|
0.0016
|
Respiratory rate (total) (breaths/min)
|
20 (15–25)
|
20 (16–24)
|
0.2406
|
Tidal volume (ml)
|
488 (400–550)
|
457 (400–516)
|
0.0105
|
Tidal volume/IBW (ml/kg)
|
7.55 (6.34–8.96)
|
7.35 (6.39–8.48)
|
0.4519
|
PEEP (cmH2O)
|
8 (5–10)
|
8 (5–10)
|
0.0254
|
Plateau pressure (cmH2O) (n = 79, n = 663)
|
24 (20–27)
|
23 (18–28)
|
0.4957
|
Peak inspiratory pressure (cmH2O)
|
27 (21–32)
|
26 (22–32)
|
0.6444
|
Mean airway pressure (cmH2O)
|
14 (11–18)
|
14 (11–18)
|
0.4912
|
Use of adjuncts
|
ECMO use
|
20 (6.5)
|
35 (1.7)
|
<.0001
|
High-dose corticosteroids
|
36 (11.7)
|
225 (10.9)
|
0.6862
|
Continuous sedation
|
234 (75.7)
|
1567 (75.8)
|
0.9861
|
Continuous neuromuscular blocking agents
|
34 (11.0)
|
286 (13.8)
|
0.1745
|
Renal replacement therapy
|
35 (11.3)
|
169 (8.2)
|
0.0648
|
Inhaled vasodilators
|
19 (6.2)
|
84 (4.1)
|
0.0928
|
Neutrophil elastase therapy
|
3 (1.0)
|
10 (0.5)
|
0.2334
|
Vasopressor used
|
163 (52.8)
|
1212 (58.6)
|
0.0518
|